Missed NVDA?
Don’t Miss the Next One.
Join 5,000+ investors using Ticker Nerd’s Market Radar to stay ahead of major market moves, analyst upgrades, and trending opportunities — for free.
PRGO Stock Forecast 2026-2027
$10.41
Current Price
$1.44B
Market Cap
Buy 2
Hold 3
Sell 0
Wall St Analyst Ratings
Distance to PRGO Price Targets
+92.1%
To High Target of $20.00
+53.7%
To Median Target of $16.00
+34.5%
To Low Target of $14.00
PRGO Price Momentum
-5.5%
1 Week Change
-6.8%
1 Month Change
-61.8%
1 Year Change
-25.2%
Year-to-Date Change
-63.4%
From 52W High of $28.44
+12.8%
From 52W Low of $9.23
📊 TOP ANALYST CALLS
Did PRGO Make This Month's Elite Buy List?
We don't follow just any analyst — only the top 3% with a proven track record make our cut. See if Perrigo is one of their latest high-conviction picks.
Latest PRGO Stock Price Targets & Analyst Predictions
Based on our analysis of 1 Wall Street analyst, PRGO has a neutral consensus with a median price target of $16.00 (ranging from $14.00 to $20.00). The overall analyst rating is Buy (7.2/10). Currently trading at $10.41, the median forecast implies a 53.7% upside. This outlook is supported by 2 Buy, 3 Hold, and 0 Sell ratings.
Please note that analyst price targets are forward-looking estimates subject to substantial market, economic, and company-specific risks. Past performance does not guarantee future results, and actual stock performance may materially differ from these projections. Investors should conduct their own due diligence and consider their investment objectives and risk tolerance before making investment decisions.
PRGO Analyst Ratings
2
Buy
3
Hold
0
Sell
PRGO Price Target Range
Low
$14.00
Average
$16.00
High
$20.00
Current: $10.41
Latest PRGO Stock Forecasts by Analyst
These are the latest 20 analyst ratings and price targets for PRGO.
| Date | Firm | Analyst | Rating | Change | Price Target |
|---|---|---|---|---|---|
| Feb 27, 2026 | Canaccord Genuity | Buy | Maintains | $N/A | |
| Dec 15, 2025 | JP Morgan | Neutral | Maintains | $N/A | |
| Nov 6, 2025 | Canaccord Genuity | Buy | Maintains | $N/A | |
| Nov 6, 2025 | JP Morgan | Neutral | Downgrade | $N/A | |
| Oct 27, 2025 | Jefferies | Hold | Maintains | $N/A | |
| Aug 7, 2025 | Canaccord Genuity | Buy | Maintains | $N/A | |
| Aug 7, 2025 | JP Morgan | Overweight | Maintains | $N/A | |
| Jan 6, 2025 | Piper Sandler | Neutral | Downgrade | $N/A | |
| Sep 30, 2024 | Canaccord Genuity | Buy | Maintains | $N/A | |
| Sep 23, 2024 | Jefferies | Hold | Downgrade | $N/A | |
| Jul 11, 2024 | Piper Sandler | Overweight | Maintains | $N/A | |
| Jun 13, 2024 | Piper Sandler | Overweight | Maintains | $N/A | |
| Apr 12, 2024 | Canaccord Genuity | Buy | Maintains | $N/A | |
| Apr 8, 2024 | Piper Sandler | Overweight | Maintains | $N/A | |
| Feb 28, 2024 | JP Morgan | Overweight | Maintains | $N/A | |
| Nov 17, 2023 | Piper Sandler | Overweight | Initiates | $N/A | |
| Aug 9, 2023 | JP Morgan | Overweight | Maintains | $N/A | |
| Mar 7, 2023 | Canaccord Genuity | Buy | Initiates | $N/A | |
| Mar 6, 2023 | Raymond James | Outperform | Maintains | $N/A | |
| Nov 9, 2022 | Raymond James | Outperform | Maintains | $N/A |
Perrigo Company plc (PRGO) Competitors
The following stocks are similar to Perrigo based on their market capitalization and industry sector. These similar stocks potentially provide investors with alternative investment opportunities within the same market segment.
Perrigo Company plc (PRGO) Financial Data
Perrigo Company plc has a market capitalization of $1.44B with a P/E ratio of 2,818.0x. The company generates $4.18B in trailing twelve-month revenue with a -43.5% profit margin.
Revenue growth is -7.2% quarter-over-quarter, while maintaining an operating margin of +3.5% and return on equity of -52.2%.
Valuation Metrics
Market Cap
$1.44B
Enterprise Value
$4.93B
P/E Ratio
2,818.0x
PEG Ratio
0.5x
Price/Sales
0.3x
Growth & Margins
Revenue Growth (YoY)
-7.2%
Gross Margin
+33.6%
Operating Margin
+3.5%
Net Margin
-43.5%
EPS Growth
-7.2%
Financial Health
Cash/Price Ratio
+24.8%
Current Ratio
2.7x
Debt/Equity
153.2x
ROE
-52.2%
ROA
+2.1%
💡 SKIP THE NOISE
97% of Analyst Ratings Go Nowhere
We filter thousands of calls to find the few that actually matter. Get the top analyst buy ratings — tracked and updated every Monday and Thursday.
Perrigo Company plc (PRGO) Business Model
About Perrigo Company plc
What They Do
Provides over-the-counter health and wellness solutions.
Business Model
Perrigo operates through two main segments: Consumer Self-Care Americas and Consumer Self-Care International. The company generates revenue by selling both store-brand private label products and branded health and wellness items, primarily through retailers, pharmacies, and online channels.
Additional Information
Headquartered in Dublin, Ireland, with operational leadership in Grand Rapids, Michigan, Perrigo offers a diverse product portfolio that includes categories like pain relief, digestive health, and infant formula. The company's strong presence in both North America and Europe positions it as a key player in the self-care market.
Company Information
Sector
Healthcare
Industry
Drug Manufacturers - Specialty & Generic
Employees
8,100
CEO
Mr. Patrick Lockwood-Taylor
Country
Ireland
IPO Year
1991
Website
www.perrigo.comPerrigo Company plc (PRGO) Latest News & Analysis
Latest News
Quick Summary
Perrigo Company plc appointed Salman Amin and Omer Gajial as independent directors, effective June 30, 2026, enhancing its Board of Directors.
Why It Matters
The appointment of independent directors can signal governance improvements and strategic shifts, potentially enhancing investor confidence and impacting stock performance.
Source: PRNewsWire
Market Sentiment:
Neutral
Perrigo CEO Ousted Over Personal Conduct
1 month ago
Quick Summary
Perrigo CEO Patrick Lockwood-Taylor has resigned due to violations of the company's code of conduct, as determined by the board.
Why It Matters
Leadership changes can impact company stability and investor confidence. A CEO's resignation over conduct issues may signal deeper problems, affecting stock performance and future strategy.
Source: WSJ
Market Sentiment:
Negative
Perrigo Announces Leadership Transition
1 month ago
Quick Summary
Perrigo Company plc has appointed Albert A. Manzone as Interim President and CEO following the resignation of Patrick Lockwood-Taylor from his positions and the Board, effective immediately.
Why It Matters
Leadership changes can create uncertainty and volatility, potentially affecting Perrigo's stock performance and strategic direction. Investors may reassess their positions based on new management.
Source: PRNewsWire
Market Sentiment:
Neutral
Quick Summary
Perrigo is rated Hold due to a distressed balance sheet and high leverage. Its 10.9% dividend yield is unsustainable, risking a cut without further divestitures. Recent asset sales offer short-term relief.
Why It Matters
Perrigo's distressed balance sheet and high leverage pose risks to its sustainability, including potential dividend cuts, impacting investor confidence and future returns.
Source: Seeking Alpha
Market Sentiment:
Positive
Quick Summary
Perrigo (PRGO) reported earnings 30 days ago; investors should monitor upcoming developments for insights on the stock's future performance.
Why It Matters
Perrigo's recent earnings report can influence stock performance and investor sentiment, impacting future price movements and investment decisions.
Source: Zacks Investment Research
Market Sentiment:
Negative
Perrigo to Present at the Oppenheimer 26th Annual Consumer Growth & E-Commerce Conference
1 month ago
Quick Summary
Perrigo Company plc's CEO and CFO will present at the Oppenheimer Consumer Growth Conference on June 9 at 10:30 AM EDT. Webcast available on their investor website.
Why It Matters
Perrigo's leadership presentation at a major conference may indicate strategic insights and future directions, influencing investor sentiment and stock performance.
Source: PRNewsWire
Market Sentiment:
Neutral
Frequently Asked Questions About PRGO Stock
What is Perrigo Company plc's (PRGO) stock forecast for 2027?
Based on our analysis of 1 Wall Street analysts, Perrigo Company plc (PRGO) has a median price target of $16.00. The highest price target is $20.00 and the lowest is $14.00.
Is PRGO stock a good investment in 2027?
According to current analyst ratings, PRGO has 2 Buy ratings, 3 Hold ratings, and 0 Sell ratings. The stock is currently trading at $10.41. Always conduct your own research and consider your investment goals before making investment decisions.
What is the long-term price prediction for PRGO stock?
Wall Street analysts predict PRGO stock could reach $16.00 in the next 12 months. This represents a 53.7% increase from the current price of $10.41. Please note that this is a projection by Wall Street analysts and not a guarantee.
What is Perrigo Company plc's business model?
Perrigo operates through two main segments: Consumer Self-Care Americas and Consumer Self-Care International. The company generates revenue by selling both store-brand private label products and branded health and wellness items, primarily through retailers, pharmacies, and online channels.
What is the highest forecasted price for PRGO Perrigo Company plc?
The highest price target for PRGO is $20.00 from at , which represents a 92.1% increase from the current price of $10.41.
What is the lowest forecasted price for PRGO Perrigo Company plc?
The lowest price target for PRGO is $14.00 from at , which represents a 34.5% increase from the current price of $10.41.
What is the overall PRGO consensus from analysts for Perrigo Company plc?
The overall analyst consensus for PRGO is neutral. Out of 1 Wall Street analysts, 2 rate it as Buy, 3 as Hold, and 0 as Sell, with a median price target of $16.00.
How accurate are PRGO stock price projections?
Stock price projections, including those for Perrigo Company plc, are based on various factors including financial models, market conditions, and analyst forecasts. While these predictions provide valuable insights, they should be considered alongside your own research and risk tolerance.
Important Disclaimer
The information provided by Ticker Nerd is for educational and informational purposes only. It should not be considered financial or investment advice. Past performance is not indicative of future results. Always conduct your own research and consult with a qualified financial advisor before making any investment decisions. Analyst ratings and price forecasts are sourced from Wall St analysts and other experts. These projections are speculative and do not guarantee future stock performance.
Last updated: July 10, 2026 3:38 AM UTC